Chiropractors in Akron, IA Accepting Medicare
4 Chiropractors found. Showing 1 - 4
 Timothy J Allard, D.C. Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 222 Reed Street, Box 135, Akron, IA 51001 Phone: 712-568-2444 Fax: 712-568-2445 |
 Britton Chiropractic & Rehab Clinic Chiropractor - Rehabilitation Medicare: Medicare Enrolled Practice Location: 351 Highway 12, Akron, IA 51001 Phone: 712-568-2307 Fax: 712-568-3792 |
Dr. Bradley Phillip Britton, D.C. Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 351 Highway 12, Akron, IA 51001 Phone: 712-568-2304 Fax: 712-568-3792 |
Timothy J Allard Dc Pc Chiropractor Medicare: Medicare Enrolled Practice Location: 222 Reed St, Box 135, Akron, IA 51001 Phone: 712-568-2444 Fax: 712-568-2445 |
News Archive
Akeso Medical Imaging closes first financing round to develop imaging device for rheumatoid arthritis disease activity monitoring and control
Akeso Medical Imaging BV, a spin-off from Philips Research, announces today the closure of its first financing round led by Thuja Capital Healthcare Seed Fund with additional financing from the Brabant Spin-Off Fund and Point-One Innovation Fund.
Merrion prepares Phase III study for Orazol in breast cancer treatment
After recent consultation with the FDA in November 2010, Merrion is preparing for its Phase III study for Orazol. If successful, the Phase III study will allow a new drug application for Orazol to be made under the FDA's abbreviated approval procedure section 505(b)(2) using a single Phase III study. The study will compare Orazol against placebo as an adjuvant breast cancer treatment with a primary endpoint of Disease Free Survival of patients with breast cancer.
Republicans plan to block health law by withholding implementation funds
Republicans may not have the numbers to repeal the health overhaul, even after the election, but they are increasingly likely to try to "deny the Obama administration the money it needs to implement the law," Politico reports.
Pharmasset declares two-for-one split of common stock
Pharmasset, Inc. announces that its Board of Directors declared a two-for-one split of Pharmasset's common stock, par value $0.001 per share, in the form of a 100% common stock dividend.
› Verified 4 days ago